pharmaceutical daily

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) is pleased to announce today’s closing of the refinancing transactions…

DUBLIN–(BUSINESS WIRE)–The “Viscosupplementation: Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. This report offers a detailed picture of…

MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address…

WOBURN, Mass.–(BUSINESS WIRE)–Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair…

NEW YORK–(BUSINESS WIRE)–Following are the latest Coronavirus news releases and story ideas for reporters, bloggers and media outlets. These recaps,…

NEWARK, Calif.–(BUSINESS WIRE)–Aradigm Corporation (OTC PINK: ARDM) (“Aradigm” or the “Company”) today announced that the Company has entered into an…

BOSTON–(BUSINESS WIRE)–Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it will present the edasalonexent program in Phase…

First approval of Opdivo for treatment of advanced esophageal cancer First Immuno-Oncology treatment option approved for patients with esophageal cancer…

CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SUZHOU, China–(BUSINESS WIRE)–Harbour BioMed (HBM) today announced completion of a Phase 1 study…

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended…